Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-08-04
1979-01-16
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31155
Patent
active
041349920
ABSTRACT:
A method useful for alleviating central nervous system depression and anxiety symptoms comprises administration to animals of an effective amount of an N,N'-dialkyl-2-naphthalene acetamidine. Compositions useful in practicing the method are also disclosed.
REFERENCES:
craver et al., J. Pharm. Exptl. Therap., 99, 353 (1950).
Abdallah Abdulmuniem H.
Shea Philip J.
Friedman Stanley J.
The Dow Chemical Company
LandOfFree
Naphthalene acetamidines as anxiolytic antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthalene acetamidines as anxiolytic antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthalene acetamidines as anxiolytic antidepressants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652136